These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 22894640)

  • 1. Omega-3 fatty acids are protective against paclitaxel-induced peripheral neuropathy: a randomized double-blind placebo controlled trial.
    Ghoreishi Z; Esfahani A; Djazayeri A; Djalali M; Golestan B; Ayromlou H; Hashemzade S; Asghari Jafarabadi M; Montazeri V; Keshavarz SA; Darabi M
    BMC Cancer; 2012 Aug; 12():355. PubMed ID: 22894640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for paclitaxel-induced peripheral neuropathy in patients with breast cancer.
    Ghoreishi Z; Keshavarz S; Asghari Jafarabadi M; Fathifar Z; Goodman KA; Esfahani A
    BMC Cancer; 2018 Oct; 18(1):958. PubMed ID: 30290775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the effect of N-acetylcysteine on the prevention and amelioration of paclitaxel-induced peripheral neuropathy in breast cancer patients: a randomized controlled study.
    Khalefa HG; Shawki MA; Aboelhassan R; El Wakeel LM
    Breast Cancer Res Treat; 2020 Aug; 183(1):117-125. PubMed ID: 32601973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of oxaliplatin-related neurotoxicity by ω-3 PUFAs: A double-blind randomized study of patients receiving oxaliplatin combined with capecitabine for colon cancer.
    Zhang X; Chen H; Lu Y; Xu C; Yao W; Xu L; Zhang R; Zhang L; Yao Q
    Medicine (Baltimore); 2020 Dec; 99(50):e23564. PubMed ID: 33327312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pilot randomized, placebo-controlled, double-blind study of omega-3 fatty acids to prevent paclitaxel-associated acute pain syndrome in breast cancer patients: Alliance A22_Pilot2.
    Tawfik B; Dayao ZR; Brown-Glaberman UA; Pankratz VS; Lafky JM; Loprinzi CL; Barton DL
    Support Care Cancer; 2023 Oct; 31(12):637. PubMed ID: 37847317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preventing paclitaxel-induced peripheral neuropathy: a phase II trial of vitamin E supplementation.
    Argyriou AA; Chroni E; Koutras A; Iconomou G; Papapetropoulos S; Polychronopoulos P; Kalofonos HP
    J Pain Symptom Manage; 2006 Sep; 32(3):237-44. PubMed ID: 16939848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen decline is a risk factor for paclitaxel-induced peripheral neuropathy: Clinical evidence supported by a preclinical study.
    Miyamoto T; Hiramoto S; Kanto A; Tsubota M; Fujitani M; Fukuyama H; Hatanaka S; Sekiguchi F; Koizumi Y; Kawabata A
    J Pharmacol Sci; 2021 May; 146(1):49-57. PubMed ID: 33858655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of gabapentin for the prevention of paclitaxel induced peripheral neuropathy: A randomized placebo controlled clinical trial.
    Aghili M; Zare M; Mousavi N; Ghalehtaki R; Sotoudeh S; Kalaghchi B; Akrami S; Esmati E
    Breast J; 2019 Mar; 25(2):226-231. PubMed ID: 30773731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of KCNQ Channels Prevents Paclitaxel-Induced Peripheral Neuropathy and Associated Neuropathic Pain.
    Li L; Li J; Zuo Y; Dang D; Frost JA; Yang Q
    J Pain; 2019 May; 20(5):528-539. PubMed ID: 30471428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glutamine as a neuroprotective agent in high-dose paclitaxel-induced peripheral neuropathy: a clinical and electrophysiologic study.
    Stubblefield MD; Vahdat LT; Balmaceda CM; Troxel AB; Hesdorffer CS; Gooch CL
    Clin Oncol (R Coll Radiol); 2005 Jun; 17(4):271-6. PubMed ID: 15997923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paclitaxel-induced sensory peripheral neuropathy is associated with an ABCB1 single nucleotide polymorphism and older age in Japanese.
    Tanabe Y; Shimizu C; Hamada A; Hashimoto K; Ikeda K; Nishizawa D; Hasegawa J; Shimomura A; Ozaki Y; Tamura N; Yamamoto H; Yunokawa M; Yonemori K; Takano T; Kawabata H; Tamura K; Fujiwara Y
    Cancer Chemother Pharmacol; 2017 Jun; 79(6):1179-1186. PubMed ID: 28447211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the efficacy of cryotherapy and compression therapy for preventing nanoparticle albumin-bound paclitaxel-induced peripheral neuropathy: A prospective self-controlled trial.
    Kanbayashi Y; Sakaguchi K; Ishikawa T; Ouchi Y; Nakatsukasa K; Tabuchi Y; Kanehisa F; Hiramatsu M; Takagi R; Yokota I; Katoh N; Taguchi T
    Breast; 2020 Feb; 49():219-224. PubMed ID: 31901783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of mitochondrial dysfunction-related genes and pathways in paclitaxel-induced peripheral neuropathy in breast cancer survivors.
    Kober KM; Olshen A; Conley YP; Schumacher M; Topp K; Smoot B; Mazor M; Chesney M; Hammer M; Paul SM; Levine JD; Miaskowski C
    Mol Pain; 2018; 14():1744806918816462. PubMed ID: 30426838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical and Clinical Evidence of Therapeutic Agents for Paclitaxel-Induced Peripheral Neuropathy.
    Kawashiri T; Inoue M; Mori K; Kobayashi D; Mine K; Ushio S; Kudamatsu H; Uchida M; Egashira N; Shimazoe T
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duloxetine to prevent neuropathy in breast cancer patients under paclitaxel chemotherapy (a double-blind randomized trial).
    Aghili M; Taherioun M; Jafari F; Azadvari M; Lashkari M; Kolahdouzan K; Ghalehtaki R; Abdshah A
    Support Care Cancer; 2024 Jul; 32(8):493. PubMed ID: 38976095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delayed recovery and increased severity of Paclitaxel-induced peripheral neuropathy in patients with diabetes.
    de la Morena Barrio P; Conesa MÁ; González-Billalabeitia E; Urrego E; García-Garre E; García-Martínez E; Poves MZ; Vicente V; de la Peña FA
    J Natl Compr Canc Netw; 2015 Apr; 13(4):417-23. PubMed ID: 25870378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perturbations in neuroinflammatory pathways are associated with paclitaxel-induced peripheral neuropathy in breast cancer survivors.
    Miaskowski C; Topp K; Conley YP; Paul SM; Melisko M; Schumacher M; Chesney M; Abrams G; Levine JD; Kober KM
    J Neuroimmunol; 2019 Oct; 335():577019. PubMed ID: 31401418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypic Characterization of Paclitaxel-Induced Peripheral Neuropathy in Cancer Survivors.
    Kober KM; Mazor M; Abrams G; Olshen A; Conley YP; Hammer M; Schumacher M; Chesney M; Smoot B; Mastick J; Paul SM; Levine JD; Miaskowski C
    J Pain Symptom Manage; 2018 Dec; 56(6):908-919.e3. PubMed ID: 30172061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurosteroid 3α-androstanediol efficiently counteracts paclitaxel-induced peripheral neuropathy and painful symptoms.
    Meyer L; Patte-Mensah C; Taleb O; Mensah-Nyagan AG
    PLoS One; 2013; 8(11):e80915. PubMed ID: 24260511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A genome-wide association study identifies novel loci for paclitaxel-induced sensory peripheral neuropathy in CALGB 40101.
    Baldwin RM; Owzar K; Zembutsu H; Chhibber A; Kubo M; Jiang C; Watson D; Eclov RJ; Mefford J; McLeod HL; Friedman PN; Hudis CA; Winer EP; Jorgenson EM; Witte JS; Shulman LN; Nakamura Y; Ratain MJ; Kroetz DL
    Clin Cancer Res; 2012 Sep; 18(18):5099-109. PubMed ID: 22843789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.